Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy

Nature

Volumn 429, Issue 6992, 2004, Pages 629-635

  Oh, Phil ^a   Li, Yan ^a   Yu, Jingyi ^a   Durr, Eberhard ^a   Krasinska, Karolina M ^a   Carver, Lucy A ^a   Testa, Jacqueline E ^a   Schnitzer, Jan E ^a  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BLOOD; CELLS; IMAGING TECHNIQUES; PROTEINS; TUMORS;

PROTEOMIC MAPPING; TISSUE-BLOOD INTERFACES;

TISSUE;

AMINOPEPTIDASE P; ANNEXIN; ANNEXIN A1 MONOCLONAL ANTIBODY I 125; ANTINEOPLASTIC AGENT; CELL SURFACE PROTEIN; CONTRAST MEDIUM; IODINE 125; LIPOCORTIN 1; MONOCLONAL ANTIBODY; RADIOISOTOPE; TUMOR PROTEIN; UNCLASSIFIED DRUG; AMINOPEPTIDASE; ANTIBODY; MEMBRANE PROTEIN; X PRO AMINOPEPTIDASE; X-PRO AMINOPEPTIDASE;

MEDICINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CANCER THERAPY; CELL FRACTIONATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIUM; GAMMA SCINTIGRAPHY; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LUNG ENDOTHELIUM; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEOMICS; RADIOIMMUNOTHERAPY; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOLID TUMOR; SOLID TUMOR ENDOTHELIUM; SUBTRACTIVE PROTEOMIC MAPPING; VALIDATION PROCESS; ANIMAL; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; BIOLOGY; CYTOLOGY; ENDOTHELIUM CELL; IMMUNOLOGY; LUNG TUMOR; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; SURVIVAL RATE; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALIA;

AMINOPEPTIDASES; ANIMALS; ANNEXIN A1; ANTIBODIES; COMPUTATIONAL BIOLOGY; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION PROFILING; HUMANS; LUNG NEOPLASMS; MASS SPECTROMETRY; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; ORGAN SPECIFICITY; PROTEOMICS; RADIOIMMUNOTHERAPY; RATS; SURVIVAL RATE;

EID: 2942529235     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02580     Document Type: Article

References (46)

1. Massoud, T. F. & Gambhir, S. S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 17, 545-580 (2003).
2. Herschman, H. R. Molecular imaging: looking at problems, seeing solutions. Science 302, 605-608 (2003).
3. Rudin, M. & Weissleder, R. Molecular imaging in drug discovery and development. Nature Rev. Drug Discov. 2, 123-131 (2003).
4. Weissleder, R. Scaling down imaging: molecular mapping of cancer in mice. Nature Rev. Cancer 2, 11-18 (2002).
5. Drews, J. Drug discovery: a historical perspective. Science 287, 1960-1964 (2000).
6. Lindsay, M. A. Target discovery. Nature Rev. Drug Discov. 2, 831-838 (2003).
7. Workman, P. New drug targets for genomic cancer therapy: successes, limitations, opportunities and future challenges. Curr. Cancer Drug Targets 1, 33-47 (2001).
8. Anzick, S. L. & Trent, J. M. Role of genomics in identifying new targets for cancer therapy. Oncology (Huntingt.) 16, 7-13 (2002).
9. Cavenee, W. K. Genetics and new approaches to cancer therapy. Carcinogenesis 23, 683-686 (2002).
10. Huber, L. A. Is proteomics heading in the wrong direction? Nature Rev. Mol. Cell Biol. 4, 74-80 (2003).
11. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
12. Jain, R. K. The next frontier of molecular medicine: delivery of therapeutics. Nature Med. 4, 655-657 (1998).
13. Dvorak, H. F., Nagy, J. A. & Dvorak, A. M. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells 3, 77-85 (1991).
14. von Mehren, M., Adams, G. P. & Weiner, L. M. Monoclonal antibody therapy for cancer. Annu. Rev. Med. 54, 343-369 (2003).
15. Farah, R. A., Clinchy, B., Herrera, L. & Vitetta, E. S. The development of monoclonal antibodies for the therapy of cancer. Crit. Rev. Eukaryot. Gene Expr. 8, 321-356 (1998).
16. Carver, L. A. & Schnitzer, J. E. Caveolae: mining little caves for new cancer targets. Nature Rev. Cancer 3, 571-581 (2003).
17. Schnitzer, J. E. Vascular targeting as a strategy for cancer therapy. N. Engl. J. Med. 339, 472-474 (1998).
18. Madri, J. A. & Williams, S. K. Capillary endothelial cell culture: Phenotype modulation by matrix components. J. Cell Biol. 97, 153-165 (1983).
19. Schnitzer, J. E. in Vascular Endothelium: Physiology, Pathology and Therapeutic Opportunities (eds Born, G. V. R. & Schwartz, C. J.) 77-95 (Schattauer, Stuttgart, 1997).
20. Aird, W. C. et al. Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J. Cell Biol. 138, 1117-1124 (1997).
21. Janzer, R. C. & Raff, M. C. Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 325, 253-257 (1987).
22. Stewart, P. A. & Wiley, M. J. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimeras. Dev. Biol. 84, 183-192 (1981).
23. Auerbach, R. et al. Specificity of adhesion between murine tumor cells and capillary endothelium: an in vitro correlate of preferential metastasis in vivo. Cancer Res. 47, 1492-1496 (1987).
24. Pasqualini, R. & Ruoslahti, E. Organ targeting in vivo using phage display peptide libraries. Nature 380, 364-366 (1996).
25. Rajotte, D. et al. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J. Clin. Invest. 102, 430-437 (1998).
26. Papetti, M. & Herman, I. M. Mechanisms of normal and tumor-derived angiogenesis. Am. J. Physiol. Cell Physiol. 282, C947-C970 (2002).
27. Ferrara, N. VEGF and the quest for tumour angiogenesis factors. Nature Rev. Cancer 2, 795-803 (2002).
28. Kerbel, R. & Folkman, J. Clinical translation of angiogenesis inhibitors. Nature Rev. Cancer 2, 727-739 (2002).
29. St Croix, B. et al. Genes expressed in human tumor endothelium. Science 289, 1197-1202 (2000).
30. Huang, X. et al. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science 275, 547-550 (1997).
31. McIntosh, D. P., Tan, X.-Y., Oh, P. & Schnitzer, J. E. Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: A pathway to overcome cell barriers to drug and gene delivery. Proc. Natl Acad. Sci. USA 99, 1996-2001 (2002).
32. Sipkins, D. A. et al. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nature Med. 4, 623-626 (1998).
33. Hu, Z. & Garen, A. Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer. Proc. Natl Acad. Sci. USA 98, 12180-12185 (2001).
34. Hood, J. D. et al. Tumor regression by targeted gene delivery to the neovasculature. Science 296, 2404-2407 (2002).
35. Oh, P. & Schnitzer, J. E. in Cell Biology: A Laboratory Handbook (ed. Celis, J.) 34-36 (Academic Press, Orlando, 1998).
36. Schnitzer, J. E., McIntosh, D. P., Dvorak, A. M., Liu, J. & Oh, P. Separation of caveolae from associated microdomains of GPI-anchored proteins. Science 269, 1435-1439 (1995).
37. Schnitzer, J. E. gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis. Am. J. Physiol. 262, H246-H254 (1992).
38. Henniker, A. J., Bradstock, K. F., Grimsley, P. & Atkinson, M. K. A novel non-lineage antigen on human leucocytes: characterization with two CD-48 monoclonal antibodies. Dis. Markers 8, 179-190 (1990).
39. Essler, M. & Ruoslahti, E. Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc. Natl Acad. Sci. USA 99, 2252-2257 (2002).
40. Perillo, N. L., Marcus, M. E. & Baum, L. G. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J. Mol. Med. 76, 402-412 (1998).
41. Gerke, V. & Moss, S. E. Annexins: from structure to function. Physiol. Rev. 82, 331-371 (2002).
42. Dreier, R., Schmid, K. W., Gerke, V. & Riehemann, K. Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study. Histochem. Cell Biol. 110, 137-148 (1998).
43. Eberhard, D. A., Brown, M. D. & VandenBerg, S. R. Alterations of annexin expression in pathological neuronal and glial reactions. Immunohistochemical localization of annexins I, II (p36 and p11 subunits), IV, and VI in the human hippocampus. Am. J. Pathol. 145, 640-649 (1994).
44. Ahn, S. H., Sawada, H., Ro, J. Y. & Nicolson, G. L. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues. Clin. Exp. Metastasis 15, 151-156 (1997).
45. McKanna, J. A. & Zhang, M. Z. Immunohistochemical localization of lipocortin 1 in rat brain is sensitive to pH, freezing, and dehydration. J. Histochem. Cytochem. 45, 527-538 (1997).
46. Bredow, S., Lewin, M., Hofmann, B., Marecos, E. & Weissleder, R. Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin. Eur. J. Cancer 36, 675-681 (2000).